Post

Contraline’s male contraceptive device trial gets sperm analysis collab

DNA Diagnostics Centre (DDC) will supply a home test kit for sperm detection to Contraline’s first-in-human trial evaluating its male …

Zealand Pharma says weight loss drug could be comparable to GLP1-RAs

Zealand Pharma believes its weight loss drug petrelintide could be comparable to glucagon like peptide-1 receptor agonists (GLP1-RAs) while providing …

Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet needs

With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the chronic kidney disease (CKD) …

Gay and bisexual men have higher risk of anxiety and depression

On 24 May, the 2024 Canadian Men’s Health Report was released; the national study surveyed 2,070 men over the age …

Oncolytics doses first subject in pancreatic cancer trial

Oncolytics Biotech has dosed the first patient with a combination therapy of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) for metastatic pancreatic …